Prognostic significance of imaging contrast enhancement for WHO grade II gliomas.
Pallud J, Capelle L, Taillandier L, Fontaine D, Mandonnet E, Guillevin R, Bauchet L, Peruzzi P, Laigle-Donadey F, Kujas M, Guyotat J, Baron MH, Mokhtari K, Duffau H.
Pallud J, et al. Among authors: mokhtari k.
Neuro Oncol. 2009 Apr;11(2):176-82. doi: 10.1215/15228517-2008-066. Epub 2008 Aug 12.
Neuro Oncol. 2009.
PMID: 18697954
Free PMC article.